Strategic Blueprint’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$666K Buy
7,262
+238
+3% +$20.8K 0.03% 391
2026
Q1
$599K Buy
7,024
+32
+0.5% +$2.85K 0.03% 378
2025
Q4
$553K Sell
6,992
-5,924
-46% -$464K 0.03% 386
2025
Q3
$1.03M Buy
12,916
+14
+0.1% +$1.19K 0.05% 335
2025
Q2
$1.17M Sell
12,902
-190
-1% -$17.3K 0.06% 279
2025
Q1
$1.23M Buy
13,092
+330
+3% +$29.5K 0.07% 249
2024
Q4
$1.16M Buy
12,762
+5,993
+89% +$572K 0.07% 241
2024
Q3
$703K Sell
6,769
-46
-0.7% -$4.69K 0.04% 325
2024
Q2
$661K Sell
6,815
-218
-3% -$20.1K 0.04% 320
2024
Q1
$633K Sell
7,033
-340
-5% -$28.8K 0.05% 337
2023
Q4
$588K Sell
7,373
-319
-4% -$24K 0.05% 330
2023
Q3
$547K Sell
7,692
-384
-5% -$28.7K 0.05% 318
2023
Q2
$622K Buy
8,076
+36
+0.4% +$2.79K 0.06% 272
2023
Q1
$604K Buy
8,040
+38
+0.5% +$2.83K 0.06% 277
2022
Q4
$630K Sell
8,002
-260
-3% -$19.5K 0.07% 253
2022
Q3
$580K Buy
8,262
+411
+5% +$32.2K 0.07% 260
2022
Q2
$629K Buy
7,851
+211
+3% +$16.5K 0.08% 242
2022
Q1
$579K Buy
7,640
+62
+0.8% +$4.91K 0.07% 257
2021
Q4
$647K Buy
7,578
+854
+13% +$66.7K 0.08% 231
2021
Q3
$508K Buy
6,724
+129
+2% +$10.2K 0.08% 236
2021
Q2
$537K Buy
6,595
+24
+0.4% +$1.96K 0.08% 224
2021
Q1
$518K Buy
6,571
+401
+6% +$31.4K 0.11% 164
2020
Q4
$528K Buy
+6,170
New +$510K 0.13% 134
2019
Q4
Sell
-803
Closed -$59K 149
2019
Q3
$59K Buy
+803
New +$58.3K 0.04% 136

Other funds holding CL

Strategic Blueprint's CL Position: Q2 2026 in Review

Strategic Blueprint increased its Colgate-Palmolive (CL) stake by 3.4% in Q2 2026, buying an estimated $20.8K and bringing the position to 7,262 shares worth $666K. The position accounts for 0.03% of the portfolio, ranked #391.

Strategic Blueprint first reported a position in CL in Q3 2019 and has held it in 24 quarters since. The position peaked at $1.23M in Q1 2025. 621 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Strategic Blueprint held 7,262 shares of Colgate-Palmolive worth $666K as of Q2 2026.
  • Strategic Blueprint bought 238 Colgate-Palmolive shares in Q2 2026, an estimated $20.8K.
  • Colgate-Palmolive made up 0.03% of Strategic Blueprint's portfolio in Q2 2026, its #391 holding.
  • Strategic Blueprint first reported a position in Colgate-Palmolive in Q3 2019 and has held it in 24 quarters since.
  • Strategic Blueprint's Colgate-Palmolive position peaked at $1.23M in Q1 2025.
  • 621 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Strategic Blueprint's 13F filing for Q2 2026, filed 23 Jul 2026.